Immunic (IMUX) Times Interest Earned (2013 - 2026)
Immunic (IMUX) reported Times Interest Earned of -$9.98 for Q1 2026, up 99.38% on a YoY basis from -$5.0 in Q1 2025, and up 91.15% sequentially from -$112.69 in Q4 2025.
Immunic (IMUX) Times Interest Earned (2013 - 2026) Analysis & Trends
Immunic (IMUX) has 14 years of Times Interest Earned data on file, last reported at -$9.98 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 99.38% year-over-year to -$9.98; the trailing twelve-month figure through Mar 2026 stood at -$32.92 (up 99.46% YoY), and the FY2025 full-year result was -$0.86, down 2.82% from the prior year.
- Times Interest Earned advanced to -$9.98 in Q1 2026, from -$112.69 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.78 in Q4 2022 to a low of -$12167.5 in Q2 2024.
- A 5-year average of -$1450.2 and a median of -$112.69 in 2025 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned tumbled 105471.56% in 2024 and soared 99.38% in 2026, its largest moves.
- Tracing IMUX's Times Interest Earned over 5 years: stood at -$0.78 in 2022, then sank by 2838.35% to -$23.06 in 2023, then plunged by 2825.21% to -$674.5 in 2024, then jumped by 83.29% to -$112.69 in 2025, then jumped by 91.15% to -$9.98 in 2026.
- Business Quant data shows IMUX's Times Interest Earned at -$9.98 in Q1 2026, -$112.69 in Q4 2025, and -$24.55 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Immunic | 11.03 Mn | 11.03 Mn | - | -9.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.98 |
| Dec 31, 2025 | -112.69 |
| Sep 30, 2025 | -24.55 |
| Jun 30, 2025 | -330.28 |
| Mar 31, 2025 | -1,612.56 |
| Dec 31, 2024 | -674.50 |
| Sep 30, 2024 | -9.21 |
| Jun 30, 2024 | -12,167.47 |
| Mar 31, 2024 | -51.67 |
| Dec 31, 2023 | -23.06 |
| Sep 30, 2023 | -196.92 |
| Jun 30, 2023 | -11.53 |
| Mar 31, 2023 | -168.81 |
| Dec 31, 2022 | -0.78 |
| Sep 30, 2022 | -8,381.67 |
| Jun 30, 2022 | -863.43 |
| Mar 31, 2022 | -14.64 |
| Dec 31, 2021 | -0.37 |
| Sep 30, 2021 | -246.94 |
| Jun 30, 2021 | -46.58 |